
Bharat Immunological & Biologicals Corporation Share Price
₹22.25 -1.71 (-7.14%)
11 Feb, 2025 20:38
Start SIP in
BIBCL
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month -15.46%
- Over 3 Month -11.88%
- Over 6 Month -27.07%
- Over 1 Year -39.83%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹22.25
-1.71
(-7.14%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹25.02
- 50 Day
- ₹25.31
- 100 Day
- ₹25.91
- 200 Day
- ₹26.92
Resistance and Support
22.86
- R3 25.93
- R2 25.11
- R1 23.68
- S1 21.43
- S2 20.61
- S3 19.18
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹22 As on 11 February, 2025 | 20:24
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹96.1 Cr As on 11 February, 2025 | 20:24
The P/E ratio of Bharat Immunological & Biologicals Corporation is -5.2 As on 11 February, 2025 | 20:24
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.1 As on 11 February, 2025 | 20:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.